Indication Segment Analysis: Age-related Macular Degeneration (AMD) (Largest Segment) vs Inflammation (Fastest-Growing Segment)

The age-related macular degeneration (AMD) segment dominated the eye health supplements market in 2026, accounting for a 34.13% share. Its leading position is supported by the increasing focus on maintaining retinal health and addressing nutritional factors associated with age-related changes in vision. Consumers seeking preventive and supportive approaches to eye wellness are increasingly interested in supplements containing nutrients associated with macular and retinal function. The growing awareness of age-related vision concerns among older populations, together with greater attention to long-term eye health, continues to sustain demand for supplements positioned around AMD-related nutritional support. The segment also benefits from the broader shift toward preventive healthcare, where consumers increasingly incorporate dietary supplements into routine wellness strategies rather than relying solely on intervention after symptoms emerge.

The inflammation indication is emerging as the fastest-growing segment as greater attention is being placed on the role of inflammatory processes in overall ocular health. Consumers are increasingly seeking nutritional products that support broader eye wellness rather than focusing exclusively on a single age-related condition. This is encouraging interest in formulations containing ingredients associated with antioxidant and anti-inflammatory support, particularly among consumers looking for preventive approaches to maintaining healthy vision. Growing awareness of lifestyle-related factors that can influence eye comfort and health is also expanding the relevance of inflammation-focused supplementation, creating favorable conditions for continued adoption of this segment.

Formulation Segment Analysis: Tablets (Largest Segment) vs Capsules (Fastest-Growing Segment)

Tablets represented the largest formulation segment in the eye health supplements market in 2026, holding a 36.25% share. Their strong market position reflects the familiarity and convenience associated with tablet-based dietary supplements, which are widely accepted by consumers across preventive health and wellness categories. Tablets can accommodate combinations of vitamins, minerals, antioxidants, and other nutritional ingredients used in eye health products, allowing manufacturers to develop formulations addressing multiple aspects of ocular wellness. Their established presence across supplement distribution channels and straightforward storage and consumption characteristics further support consumer acceptance. In addition, the familiarity of tablet formats can reduce barriers to regular supplementation, reinforcing their continued importance within eye health products.

Capsules are projected to experience the fastest growth as consumers increasingly favor convenient supplement formats that fit easily into daily wellness routines. Capsule formulations can offer flexibility in delivering combinations of nutritional ingredients while providing a familiar alternative for consumers who prefer this dosage format. Growing interest in targeted supplementation and personalized wellness is encouraging demand for products designed around specific health needs, including vision and ocular support. The increasing emphasis on ease of consumption, portability, and routine adherence is also strengthening the appeal of capsules, allowing this formulation segment to gain momentum as consumers become more selective about both the nutritional composition and usability of eye health supplements.